Collaborative Computational Technologies for Biomedical Research (eBook)
576 Seiten
John Wiley & Sons (Verlag)
978-1-118-02602-1 (ISBN)
"The time has come to fundamentally rethink how we handle the
building of knowledge in biomedical sciences today. This book
describes how the computational sciences have transformed into
being a key knowledge broker, able to integrate and operate across
divergent data types."--Bryn Williams-Jones, Associate Research
Fellow, Pfizer
The pharmaceutical industry utilizes an extended network of
partner organizations in order to discover and develop new drugs,
however there is currently little guidance for managing information
and resources across collaborations.
Featuring contributions from the leading experts in a range of
industries, Collaborative Computational Technologies for Biomedical
Research provides information that will help organizations make
critical decisions about managing partnerships, including:
* Serving as a user manual for collaborations
* Tackling real problems from both human collaborative and data
and informatics perspectives
* Providing case histories of biomedical collaborations and
technology-specific chapters that balance technological depth with
accessibility for the non-specialist reader
A must-read for anyone working in the pharmaceuticals industry
or academia, this book marks a major step towards widespread
collaboration facilitated by computational technologies.
SEAN EKINS, MSc, PhD, DSc, is the Principal at Collaborations in Chemistry, and Collaborations Director at Collaborative Drug Discovery, Inc., as well as an Adjunct Associate Professor in the Department of Pharmaceutical Sciences, University of Maryland School of Pharmacy. He has published more than 170 papers and book chapters on computational and in vitro drug discovery approaches and has previously edited or co-edited three books for Wiley. MAGGIE A. Z. HUPCEY, PhD, is a chemist working within the Life Sciences and Healthcare Practice of PA Consulting Group in Princeton, New Jersey. She has worked on collaborative projects for the design and development of new products and processes in the medical device, drug delivery, and drug discovery fields, including presubmission and post-launch regulatory compliance activities. ANTONY J. WILLIAMS, PhD, FRSC, is currently Vice President, Strategic Development, at the Royal Society of Chemistry and holds an adjunct position at UNC-Chapel Hill. He has written chapters for many books and published more than 100 peer-reviewed papers and book chapters on NMR, predictive ADME methods, Internet-based tools, crowdsourcing, and database curation. He is an active blogger and participant in the Internet chemistry network.
FOREWORD xi
Alpheus Bingham
PREFACE xv
CONTRIBUTORS xix
PART I GETTING PEOPLE TO COLLABORATE 1
1. The Need for Collaborative Technologies in Drug Discovery 3
Chris L. Waller, Ramesh V. Durvasula, and Nick Lynch
2. Collaborative Innovation: The Essential Foundation of Scientific Discovery 19
Robert Porter Lynch
3. Models for Collaborations and Computational Biology 39
Shawnmarie Mayrand-Chung, Gabriela Cohen-Freue, and Zsuzsanna Hollander
4. Precompetitive Collaborations in the Pharmaceutical Industry 55
Jackie Hunter
5. Collaborations in Chemistry 85
Sean Ekins, Antony J. Williams, and Christina K. Pikas
6. Consistent Patterns in Large-Scale Collaboration 99
Robin W. Spencer
7. Collaborations Between Chemists and Biologists 113
Victor J. Hruby
8. Ethics of Collaboration 121
Richard J. McGowan, Matthew K. McGowan, and Garrett J. McGowan
9. Intellectual Property Aspects of Collaboration 133
John Wilbanks
PART II METHODS AND PROCESSES FOR COLLABORATIONS 147
10. Scientific Networking and Collaborations 149
Edward D. Zanders
11. Cancer Commons: Biomedicine in the Internet Age 161
Jeff Shrager, Jay M. Tenenbaum, and Michael Travers
12. Collaborative Development of Large-Scale Biomedical Ontologies 179
Tania Tudorache and Mark A. Musen
13. Standards for Collaborative Computational Technologies for Biomedical Research 201
Sean Ekins, Antony J. Williams, and Maggie A. Z. Hupcey
14. Collaborative Systems Biology: Open Source, Open Data, and Cloud Computing 209
Brian Pratt
15. Eight Years Using Grids for Life Sciences 221
Vincent Breton, Lydia Maigne, David Sarramia, and David Hill
16. Enabling Precompetitive Translational Research: A Case Study 241
Sándor Szalma
17. Collaboration in Cancer Research Community: Cancer Biomedical Informatics Grid (caBIG) 261
George A. Komatsoulis
18. Leveraging Information Technology for Collaboration in Clinical Trials 281
O. K. Baek
PART III TOOLS FOR COLLABORATIONS 301
19. Evolution of Electronic Laboratory Notebooks 303
Keith T. Taylor
20. Collaborative Tools to Accelerate Neglected Disease Research: Open Source Drug Discovery Model 321
Anshu Bhardwaj, Vinod Scaria, Zakir Thomas, Santhosh Adayikkoth, Open Source Drug Discovery (OSDD) Consortium, and Samir K. Brahmachari
21. Pioneering Use of the Cloud for Development of Collaborative Drug Discovery (CDD) Database 335
Sean Ekins, Moses M. Hohman, and Barry A. Bunin
22. Chemspider: a Platform for Crowdsourced Collaboration to Curate Data Derived From Public Compound Databases 363
Antony J. Williams
23. Collaborative-Based Bioinformatics Applications 387
Brian D. Halligan
24. Collaborative Cheminformatics Applications 399
Rajarshi Guha, Ola Spjuth, and Egon Willighagen
PART IV THE FUTURE OF COLLABORATIONS 423
25. Collaboration Using Open Notebook Science in Academia 425
Jean-Claude Bradley, Andrew S. I. D. Lang, Steve Koch, and Cameron Neylon
26. Collaboration and the Semantic Web 453
Christine Chichester and Barend Mons
27. Collaborative Visual Analytics Environment for Imaging Genetics 467
Zhiyu He, Kevin Ponto, and Falko Kuester
28. Current and Future Challenges for Collaborative Computational Technologies for the Life Sciences 491
Antony J. Williams, Renée J. G. Arnold, Cameron Neylon, Robin W. Spencer, Stephan Schürer, and Sean Ekins
INDEX 519
"The book is of interest to researchers developing IT systems in
the pharmaceutical industry, and for those participating in drug
discovery collaborations." (Book News, 1 October 2011)
"What unveiled itself as I turned the pages was ... a truthful,
meaningful accounting of an evolving social science, perhaps a hope
that the pure thrill of crowdsourcing may accelerate the process of
discovery while preserving a free market economy.... The book
contains... [contributions from a] multi-national task force if you
will of some of the world's finest minds in life and physical
science and 'cloud-native' knowledge-sharing." (Untangled
Health, 11 August 2011)
Erscheint lt. Verlag | 4.8.2011 |
---|---|
Reihe/Serie | Wiley Series on Technologies for the Pharmaceutical | Wiley Series on Technologies for the Pharmaceutical |
Vorwort | Alpheus Bingham |
Sprache | englisch |
Themenwelt | Medizin / Pharmazie ► Gesundheitsfachberufe |
Medizin / Pharmazie ► Medizinische Fachgebiete ► Biomedizin | |
Naturwissenschaften ► Biologie | |
Technik ► Umwelttechnik / Biotechnologie | |
Schlagworte | Bioinformatics & Computational Biology • Bioinformatik • Bioinformatik u. Computersimulationen in der Biowissenschaften • biomedical engineering • Biomedizin • Biomedizintechnik • Biowissenschaften • Chemie • Chemistry • Drug Discovery & Development • Life Sciences • Medical Informatics & Biomedical Information Technology • Medizininformatik u. biomedizinische Informationstechnologie • Wirkstoffforschung • Wirkstoffforschung u. -entwicklung |
ISBN-10 | 1-118-02602-0 / 1118026020 |
ISBN-13 | 978-1-118-02602-1 / 9781118026021 |
Haben Sie eine Frage zum Produkt? |
Größe: 12,7 MB
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: PDF (Portable Document Format)
Mit einem festen Seitenlayout eignet sich die PDF besonders für Fachbücher mit Spalten, Tabellen und Abbildungen. Eine PDF kann auf fast allen Geräten angezeigt werden, ist aber für kleine Displays (Smartphone, eReader) nur eingeschränkt geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
Größe: 10,4 MB
Kopierschutz: Adobe-DRM
Adobe-DRM ist ein Kopierschutz, der das eBook vor Mißbrauch schützen soll. Dabei wird das eBook bereits beim Download auf Ihre persönliche Adobe-ID autorisiert. Lesen können Sie das eBook dann nur auf den Geräten, welche ebenfalls auf Ihre Adobe-ID registriert sind.
Details zum Adobe-DRM
Dateiformat: EPUB (Electronic Publication)
EPUB ist ein offener Standard für eBooks und eignet sich besonders zur Darstellung von Belletristik und Sachbüchern. Der Fließtext wird dynamisch an die Display- und Schriftgröße angepasst. Auch für mobile Lesegeräte ist EPUB daher gut geeignet.
Systemvoraussetzungen:
PC/Mac: Mit einem PC oder Mac können Sie dieses eBook lesen. Sie benötigen eine
eReader: Dieses eBook kann mit (fast) allen eBook-Readern gelesen werden. Mit dem amazon-Kindle ist es aber nicht kompatibel.
Smartphone/Tablet: Egal ob Apple oder Android, dieses eBook können Sie lesen. Sie benötigen eine
Geräteliste und zusätzliche Hinweise
Buying eBooks from abroad
For tax law reasons we can sell eBooks just within Germany and Switzerland. Regrettably we cannot fulfill eBook-orders from other countries.
aus dem Bereich